CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 31.49% | — | — | |
| 2 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 7.90% | +0.47% | — | |
| 3 | DVAX | Dynavax Technologies CORP | Stock-Other | 7.60% | — | +8.04% | |
| 4 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 7.53% | — | — | |
| 5 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 7.12% | — | — | |
| 6 | ANNX | Annexon INC | Stock-Other | 4.78% | +0.58% | — | |
| 7 | CCCC | C4 Therapeutics INC | Stock-Other | 4.07% | +0.65% | — | |
| 8 | PHVS | Pharvaris N.V. | Stock-Other | 3.88% | +0.86% | — | |
| 9 | ✓ | Mersana Therapeutics INC | Stock-Other | 3.29% | — | — | |
| 10 | NRIX | Nurix Therapeutics INC | Stock-Other | 2.23% | — | — | |
| 11 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 2.07% | — | +56.77% | |
| 12 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 2.07% | — | — | |
| 13 | SLDB | Solid Biosciences Inc. | Stock-Other | 1.90% | — | — | |
| 14 | MRNS* | Marinus Pharmaceuticals INC | Stock-Other | 1.68% | — | — | |
| 15 | ✓ | Aptinyx INC | Stock-Other | 1.65% | — | — | |
| 16 | KYMR | Kymera Therapeutics INC | Stock-Other | 1.52% | — | — | |
| 17 | NAUT | Nautilus Biotechnology INC | Stock-Other | 1.32% | — | — | |
| 18 | SVRA | Savara INC | Stock-Other | 1.29% | +0.54% | — | |
| 19 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 1.23% | — | — | |
| 20 | ✓ | Stock-Other | 1.13% | — | — | ||
| 21 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 0.90% | — | — | |
| 22 | ✓ | Bctg Acquisition CORP | Stock-Other | 0.69% | — | +84.36% | |
| 23 | ✓ | Research Alliance CORP Ii | Stock-Other | 0.66% | — | — | |
| 24 | ✓ | Arya Sciences Acqu CORP Iv | Stock-Other | 0.49% | — | — | |
| 25 | ✓ | Bcls Acquisition CORP | Stock-Other | 0.34% | — | — | |
| 26 | ✓ | Panacea Acquisition CORP Ii | Stock-Other | 0.33% | — | — | |
| 27 | ✓ | Omega Alpha Spac | Stock-Other | 0.26% | — | — | |
| 28 | ✓ | Frazier Lifesciences Acqu Co | Stock-Other | 0.20% | — | — | |
| 29 | ✓ | Jiya Acquisition CORP | Stock-Other | 0.20% | — | — | |
| 30 | ✓ | Moonlake Immunotherapeutics | Stock-Other | 0.17% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | +7.2% | — | Unchanged |
| 2 | DRNAUSD | Dicerna Pharmaceuticals INC | +3.1% | — | Unchanged |
| 3 | DVAX | Dynavax Technologies CORP | +1.5% | +8.04% | Add |
| 4 | CRNX | Crinetics Pharmaceuticals In | +1.1% | +56.77% | Add |
| 5 | CCCC | C4 Therapeutics INC | +0.6% | — | Unchanged |
| 6 | ARQT | Arcutis Biotherapeutics INC | +0.6% | — | Unchanged |
| 7 | KYMR | Kymera Therapeutics INC | +0.5% | — | Unchanged |
| 8 | MRNS* | Marinus Pharmaceuticals INC | +0.4% | — | Unchanged |
| 9 | ✓ | Bctg Acquisition CORP | +0.4% | +84.36% | Add |
| 10 | ✓ | +0.2% | — | Unchanged | |
| 11 | ✓ | Aptinyx INC | +0.1% | — | Unchanged |
| 12 | ✓ | Research Alliance CORP Ii | +0.1% | — | Unchanged |
| 13 | ✓ | Arya Sciences Acqu CORP Iv | +0.1% | — | Unchanged |
| 14 | ✓ | Bcls Acquisition CORP | +0.1% | — | Unchanged |
| 15 | ✓ | Omega Alpha Spac | 0% | — | Unchanged |
| 16 | ✓ | Moonlake Immunotherapeutics | 0% | — | Unchanged |
| 17 | ✓ | Frazier Lifesciences Acqu Co | 0% | — | Unchanged |
| 18 | ✓ | Jiya Acquisition CORP | 0% | — | Unchanged |
| 19 | AGLEUSD | Aeglea Biotherapeutics INC | 0% | — | Unchanged |
| 20 | NRIX | Nurix Therapeutics INC | 0% | — | Unchanged |
| 21 | SVRA | Savara INC | -0.1% | — | Unchanged |
| 22 | ✓ | Mersana Therapeutics INC | -0.1% | — | Unchanged |
| 23 | ASNSUSD | X4 Pharmaceuticals INC | -0.1% | — | Unchanged |
| 24 | ANNX | Annexon INC | -0.3% | — | Unchanged |
| 25 | SYRSEUR | Syros Pharmaceuticals INC | -0.4% | — | Unchanged |
| 26 | SLDB | Solid Biosciences Inc. | -0.6% | — | Unchanged |
| 27 | PHVS | Pharvaris N.V. | -1.2% | — | Unchanged |
| 28 | AVIR | Atea Pharmaceuticals INC | -11.7% | — | Unchanged |
| 29 | CNST | Constellation Pharmaceutical | — | EXIT | Sold out |
| 30 | NAUT | Nautilus Biotechnology INC | — | NEW | New buy |
| 31 | ✓ | Arya Sciences Acquisition Co | — | EXIT | Sold out |
| 32 | ✓ | Therapeutics Acquisition Cor | — | EXIT | Sold out |
| 33 | ✓ | Panacea Acquisition CORP Ii | — | NEW | New buy |